Analysts Lower 12-Month Price Target for Medical Properties Trust, Inc.
Analysts have reduced the average 12-month price target for Medical Properties Trust, Inc. to $3.25, citing updated market forecasts.
Stocks · News reference
Law Firms Initiate Securities Fraud Investigations into Medical Properties Trust, Inc.
Multiple law firms have announced ongoing securities fraud investigations into Medical Properties Trust, Inc. following the company's October 29, 2026, disclosure regarding tenant rent payment issues.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BNP Paribas Downgrades Medical Properties Trust to Neutral
BNP Paribas has downgraded Medical Properties Trust from Outperform to Neutral, setting a price target of $2.25.
RBC Capital Downgrades Medical Properties Trust to Underperform, Lowers Price Target to $2
RBC Downgrades Medical Properties Trust to Underperform
RBC Capital Markets downgraded Medical Properties Trust to Underperform from Sector Perform and lowered its price target to $2 from $4.50.
Medical Properties Trust Reports Third Quarter 2026 Financial Results
Medical Properties Trust, Inc. announced its financial and operating results for the third quarter ended September 30, 2026, reporting net income of $0.34 per share and Normalized Funds from Operations (NFFO) of $0.11 per share.
8-K filing — MEDICAL PROPERTIES TRUST INC (MPT)
Filed: 2026-10-29 AccNo: 0001193125-26-437067 Size: 7 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits